Related Experiment Video
Updated: Feb 8, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Is There a Role for Thiopurines in IBD?
Raymond K Cross1, Hans Herfarth1,1
1Department of Medicine, Division of Gastroenterology and Hepatology, University of Maryland School of Medicine Baltimore, Baltimore, MD, USA. Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC, USA. University of North Carolina Multidisciplinary Center for Inflammatory Bowel Diseases, Chapel Hill, NC, USA.
Immunosuppressive therapy (IM) offers a cost-effective option for some inflammatory bowel disease (IBD) patients. However, early biologic therapy provides better outcomes for most, necessitating better risk identification and cost containment strategies.
Area of Science:
- Gastroenterology
- Immunology
- Pharmacology
Background:
- Immunosuppressive therapy (IM) is an affordable treatment option for inflammatory bowel disease (IBD).
- Approximately one-third of IBD patients benefit from IM.
- IM may be suitable for IBD patients with a low risk of severe disease or colectomy, or limited access to biologics.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
The Role of Culture
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

